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Abstract 25 
 26 
Enzymatic hydrolysis of whey protein (WP) was carried out under pH-controlled and 27 
non pH-controlled conditions using papain and a microbial-derived alternative (papain-like 28 
activity). The impact of such conditions on physicochemical and bioactive properties was 29 
assessed. WP hydrolysates (WPH) generated with the same enzyme displayed similar degree 30 
of hydrolysis. However, their reverse-phase liquid chromatograph mass spectrometry peptide 31 
profiles differed. A significantly higher oxygen radical absorbance capacity (ORAC) value 32 
was obtained for WP hydrolysed with papain at constant pH of 7.0 compared to the 33 
associated WPH generated without pH regulation. In contrast, there was no significant effect 34 
of pH regulation on dipeptidyl peptidase IV (DPP-IV) properties. WP hydrolysed with the 35 
papain-like activity under pH regulation at 7.0 displayed higher ORAC activity and DPP-IV 36 
inhibitory properties compared to the associated WPH generated without pH regulation. This 37 
study has demonstrated that pH conditions during WPH generation may impact on peptide 38 
release and therefore on WPH bioactive properties. 39 
 40 
 41 
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1 Introduction 44 
 45 
Food protein-derived peptides have significant industrial relevance as they are 46 
associated with health benefits such as antidiabetic, antioxidant and antihypertensive 47 
properties (Hernández-Ledesma, García-Nebot, Fernández-Tomé, Amigo & Recio, 2014; 48 
Korhonen & Pihlanto, 2006; Li-Chan, 2015; Nongonierma & FitzGerald, 2015; Power, 49 
Jakeman & FitzGerald, 2013). The main approach used to generate bioactive peptides is by 50 
enzymatic hydrolysis, however, the outcome in term of the peptides released may be highly 51 
dependent on the processing conditions employed (Wei & Zhimin, 2006; Whitehurst & Law, 52 
2002). Indeed, parameters such as the enzyme preparation, protein concentration, pH, 53 
duration of the process and incubation temperature have been shown to influence the peptide 54 
composition of hydrolysates. Therefore, the processing condition used for the generation of 55 
protein hydrolysates can impact the release of peptides and thus may alter the bioactive 56 
profile of the resultant hydrolysate (van der Ven, Gruppen, de Bont & Voragen, 2002). 57 
pH is an important parameter which can vary during the hydrolysis process, as the 58 
peptide bonds cleavage can modify the buffering capacity of the solution (Wei, et al., 2006). 59 
However, the pH can be regulated throughout hydrolysis using a pH stat approach. This 60 
strategy allows maintenance of the pH at the enzymes’ optimum throughout the reaction. 61 
Nevertheless this method involves the addition of a titrant (acid or alkaline) to maintain the 62 
target pH. This results in additional salts in the final hydrolysates. That is why an alternative 63 
strategy commonly employed in industries consists of adjusting the initial pH to the enzymes’ 64 
optimum and then allowing the pH to change during the course of the hydrolysis reaction 65 
without further addition of a titrant. However, as the tertiary structure of enzymes is pH 66 
dependant, even small changes in pH during the course of a non pH-controlled reaction may 67 
affect the conformation of the enzyme. As a result, this may affect its hydrolytic activity 68 
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(Whitehurst, et al., 2002). For instance, hydrolysis of β-lactoglobulin by trypsin at optimal 69 
pH (pH 7.8) and at lower pHs showed few differences in the generation of peptides and also 70 
in the kinetics of peptide release (Cheison, Lai, Leeb & Kulozik, 2011). It was also shown 71 
that the extent of whey protein isolate hydrolysis with trypsin was dependent on the pH 72 
(Cheison, Leeb, Toro-Sierra & Kulozik, 2011). Indeed, altering the pH allowed to modify the 73 
proportion of hydrolysed α-lactalbumin, β-lactoglobulin variant A or B after 5 min 74 
hydrolysis. 75 
Food-grade industrial enzyme preparations are derived from a wide range of animal, 76 
microbial and plant sources. Therefore, these preparations mostly contain mixtures of enzyme 77 
activities, each possessing their own unique properties and optimum pH values (Whitehurst, 78 
et al., 2002). For this reason, the specific enzymatic activity of a preparation may vary with 79 
pH leading to the generation of different peptides. The resultant change in peptide profile 80 
may impact on the hydrolysate physicochemical and bioactive properties. 81 
The aim of this study was to compare the impact of whey protein (WP) proteolysis, 82 
under pH control and uncontrolled conditions, on the physicochemical and bioactive 83 
properties of the food protein hydrolysates. The WP substrate was hydrolysed with two 84 
different food-grade enzymatic preparations. Physicochemical properties of the resulting WP 85 
hydrolysates (WPH) were then analysed. Their peptide profile and degree of hydrolysis (DH) 86 
were studied. With regard to bioactivity, the inhibition of dipeptidyl peptidase IV (DPP-IV) 87 
was employed as an in vitro indicator of an antidiabetic effect as inhibition of this enzyme is 88 
a target for the improvement of serum glucose regulation in type-2 diabetes (Juillerat-89 
Jeanneret, 2014; Tulipano, Faggi, Nardone, Cocchi & Caroli, 2015). Moreover, as a high 90 
oxidative status may occur in type-2 diabetic patients, the antioxidant capacity of the 91 
hydrolysates generated was analysed (Rani & Mythili, 2014). Consequently, the novelty of 92 
this study was to highlight the impact of pH controlled vs. non pH controlled conditions 93 
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regarding WPH physicochemistry, antioxidant and antidiabetic bioactivities, as it has not 94 
been systematically studied, to our knowledge. 95 
 96 
2 Materials and methods 97 
 98 
2.1 Reagents 99 
The WP substrate (81% w/w protein) was obtained from Carbery Group (Ballineen, 100 
Ireland). Gly-Pro-pNA, diprotin A (IPI), porcine DPP-IV (≥ 10 units mg-1 protein), 101 
trifluoroacetic acid (TFA), tris(hydroxymethyl)aminomethane (TRIS), Trolox, 2,2’-azobis (2-102 
amidinopropane) dihydrochloride (AAPH) radical, mass spectrometry (MS) grade water and 103 
acetonitrile (MeCN) were purchased from Sigma Aldrich (Dublin, Ireland). Hydrochloric 104 
acid (HCl), sodium hydroxide (NaOH) high pressure liquid chromatography (HPLC) grade 105 
water and MeCN were provided by VWR (Dublin, Ireland). 2,4,6-Trinitrobenzenesulfonic 106 
acid (TNBS) was obtained from Pierce Biotechnology (Medical Supply, Dublin, Ireland). 107 
Two food-grade proteolytic preparations were used in this study as they were 108 
previously shown to yield quinoa protein hydrolysates with similar physicochemical and 109 
bioactive properties (Nongonierma, Le Maux, Dubrulle, Barre & FitzGerald, 2015). These 110 
enzyme preparations consisted of a proteinase preparation from Carica papaya latex (papain, 111 
activity: 100 papain TU/mg,) and its microbial-derived alternative (papain-like, activity: 154 112 
casein protease units/g), both from Biocatalysts (Cefn Coed, Wales, UK). Each preparation 113 
contained several proteinases with broad specificities. Both had similar optimum condition 114 
ranges, with pH of 5.0 and 7.5, and temperature of 50 and 70ºC. 115 
All other chemicals were obtained from Sigma Aldrich and were of analytical grade 116 
unless otherwise stated. 117 
 118 
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2.2 Enzymatic hydrolysis of WP 119 
Hydrolyses were carried out as described by Nongonierma, Le Maux, et al. (2015) 120 
with minor modifications. Briefly, WP was resuspended at 5% (w/w) in distilled water and 121 
rehydrated at 50ºC for 30 min under agitation. The solutions were adjusted to the desired pH 122 
(see below) using NaOH (0.5 M) or HCl (0.1 M). Two different enzyme preparations were 123 
used to hydrolyse WP: a papain preparation (P) and its microbial-derived alternative (papain-124 
like, PL). The enzyme was added at an enzyme to substrate (E:S) ratio of 2% (v/w) and 125 
hydrolysis was carried out at 50ºC for 3 h under agitation. Hydrolysis was terminated by heat 126 
inactivating the enzyme in a water bath at 90ºC for 20 min or 100ºC for 40 min for PL and P, 127 
respectively. The hydrolysates generated with the papain (WPH-P) and with the papain-like 128 
enzyme (WPH-PL) were then freeze-dried (FreeZone 18L, Labconco, Kansas City, MO, 129 
USA) and stored at -20ºC prior to further analysis. 130 
Hydrolyses reactions carried out under pH stat (controlled pH) conditions (Titrando 131 
843, Tiamo 1.4 Metrohm, Dublin, Ireland) were initially adjusted and maintained at pH 7.0 132 
for both enzyme preparations. The hydrolysis reactions carried out without pH control were 133 
also initially adjusted to pH 7.0. On termination of the reaction, it was observed that the pH 134 
had dropped to 6.1 and 6.3 for the WPH-PL and WPH-P, respectively. Therefore, hydrolysis 135 
was also carried out under pH controlled conditions at pH 6.1 for PL and 6.3 for P. Each 136 
hydrolysis reaction was performed in triplicate. 137 
 138 
2.3 Quantification of the degree of hydrolysis (DH) using the trinitrobenzenesulfonic acid 139 
(TNBS) method 140 
The degree of hydrolysis (DH) was quantified using the TNBS method according to 141 
Adler-Nissen (1979) and as described by Hernández-Herrero, Roig-Sagués, López-Sabater, 142 
Rodríguez-Jerez and Mora-Ventura (1999) with modifications. Samples (0.25-1.00 g L
-1
) 143 
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were prepared in 1% (w/v) sodium dodecyl sulphate (SDS) solution and incubated at 50ºC for 144 
1 h. Samples (10 µL) were added to 80 µL of sodium phosphate buffer (0.2125 M, pH8.2) 145 
and 80 µL of 0.1% (w/v) TNBS in a 96-well microplate. The microplate was incubated at 146 
50ºC and the absorbance was read at 420 nm every 5 min for 1 h using a plate reader (Biotek 147 
Synergy HT, Winoosky, VT, USA). Leucine was used as a standard (at concentrations 148 
ranging from 0 to 4 mM) to allow determination of the free amino group content of the 149 
samples (AN, in mg N mg
-1
 sample). DH was measured using the following formula: 150 
% 𝐷𝐻 =  
𝐴𝑁𝑊𝑃𝐻 − 𝐴𝑁𝑢𝑛ℎ𝑦𝑑𝑟𝑜𝑙𝑦𝑠𝑒𝑑 𝑊𝑃
𝑁𝑝𝑏
× 100 
A value of 123.3 mg g
-1
 was used as the nitrogen content of the peptide bonds (Npb) 151 
for WP (Spellman, McEvoy, O’Cuinn & FitzGerald, 2003). Each sample was analysed in 152 
triplicate. 153 
 154 
2.4 Sample analysis by polyacrylamide gel electrophoresis 155 
WP and WPH were analysed by SDS polyacrylamide gel electrophoresis (SDS-156 
PAGE). Mini-PROTEAN TGX precast Gels (4-20 % resolving gel, Bio-Rad Laboratories 157 
Inc., Hercules, CA) were used on a Mini Protean II system (Bio-Rad) according to the 158 
manufacturer’s instructions. Samples were prepared under reducing conditions (with β-159 
mercaptoethanol). A wide range molecular weight calibration kit (6,500-200,000 Da, Sigma 160 
Aldrich) was used as molecular weight standards. 161 
 162 
2.5 Analytical chromatography 163 
Gel permeation high performance liquid chromatography (GP-HPLC) was used to 164 
determine the molecular mass distribution at 214 nm of the hydrolysates as described by 165 
Nongonierma and FitzGerald (2012). 166 
 167 
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2.6 Sample analysis by reverse phase ultra-performance liquid chromatograph mass 168 
spectrometry (RP-UPLC-MS/MS) 169 
Samples were analysed on RP-UPLC-MS/MS, using a Waters Acquity UPLC system 170 
(Waters, Milford, MA) coupled to an Impact HD (Quadrupole, Time-of-Flight) mass 171 
spectrometer (Bruker Daltonics GmbH, Bremen, Germany) as described by Le Maux, 172 
Nongonierma, Murray, Kelly and FitzGerald (2015). Briefly, the UPLC system was equipped 173 
with a tunable UV detector set at 214 and 280 nm. The mass spectrometer was fitted with an 174 
electrospray ionisation (ESI) source and was used in the positive ion mode. Instrument 175 
control and data acquisition were performed using Hystar software (Bruker Daltonics GmbH) 176 
as described by Le Maux, et al. (2015) 177 
Data were analysed using ProfileAnalysis (Bruker Daltonics GmbH). Visualisation of 178 
peptide peak intensities was carried out with Venn diagrams using the venn function (Version 179 
1.7) on Matlab R2015a (The MathWorks Inc., Natick, MA). Only peaks with a high intensity 180 
(threshold of 3 × 10
5
) were analysed. The number of peptides with similar intensities for all 181 
samples represented in the diagram were reported at the intersection of all the samples. 182 
Peptide peaks having different intensities (4 fold differences and P-value of 0.05) were 183 
reported in the zone representing the hydrolysates which had the highest intensity for these 184 
peaks. 185 
 186 
2.7 DPP-IV inhibition assay 187 
The DPP-IV inhibitory activity of each sample was determined as described by 188 
Nongonierma and FitzGerald (2013a). The WPH were resuspended in HPLC water at a 189 
concentration ranging from 2.5 10
-3
 to 2.5 mg mL
-1
. The DPP-IV IC50 values were determined 190 
by plotting the percentage inhibition as a function of the WPH concentration expressed in mg 191 
dry powder mL
-1
. Each sample was analysed in triplicate. 192 
 9 
 
 193 
2.8 Determination of the antioxidant capacity using the oxygen radical absorbance 194 
capacity (ORAC) assay 195 
The antioxidant capacity of each sample was determined using the ORAC assay as 196 
per Zulueta, Esteve and Frígola (2009), with some modifications described by Nongonierma, 197 
Le Maux, et al. (2015). WP and WPH were tested at a final concentration of 8 mg L
-1
. The 198 
ORAC values were expressed as μmol of Trolox equivalents (TE) per g of dry powder. Each 199 
sample was analysed in triplicate. 200 
 201 
2.9 Statistical analysis 202 
Results are presented as the mean of triplicate determinations ± SD. Results were 203 
compared with R software 3.1.0 package (R Foundation for Statistical Computing, Vienna, 204 
Austria) using the Rcmdr library version 2.1-7 and an ANOVA system with a Tukey’s test at 205 
a significance level P < 0.05. 206 
 207 
3 Results 208 
 209 
3.1 Degree of hydrolysis of WPH 210 
The DH of the WPH samples are presented in Table 1. All the WPH-P were of the 211 
same order of % DH (P > 0.05). Likewise, there was no significant difference between all the 212 
WPH-PL samples (P > 0.05). However, the WPH-PL were significantly more hydrolysed 213 
than the WPH-P (P < 0.05), with DH of 4.93 ± 0.06 % and 10.80 ± 0.32 % for WPH-P-pH 7 214 
and WPH-PL-pH 7, respectively. 215 
 216 
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3.2 Molecular mass distribution of WP samples by GP-HPLC and polyacrylamide gel 217 
electrophoresis 218 
Protein hydrolysis was observed by GP-HPLC, which highlighted the breakdown of 219 
the high molecular mass (> 10 kDa) components within all the WPH samples as compared to 220 
WP (Figure 1). The GP-HPLC peptide profiles showed a higher proportion of short peptides 221 
(< 1 kDa) in the WPH-PL than in the WPH-P samples. WPH-P-pH 7 had the highest 222 
proportion of high molecular mass (26.8 % of compounds > 10 kDa) and WPH-PL-pH 7, the 223 
lowest (11.1 % of compounds > 10 kDa). 224 
Similar results were observed by reducing SDS-PAGE analysis, showing greater 225 
protein hydrolysis in WPH-PL compared to WPH-P samples. Moreover, bands of intact 226 
proteins, such as bovine serum albumin (BSA) at 66 kDa, could only be observed in the 227 
WPH-P samples (Supplementary data Fig. S1). 228 
 229 
3.3 Peptide profile of WPH by RP-UPLC-MS/MS 230 
All replicates of the same WPH had similar peptide profiles (data not shown). 231 
Furthermore, WPH samples produced with the same enzyme preparation had comparable 232 
peptide profiles, with certain peaks displaying different intensities under certain pH 233 
conditions (some examples are indicated by red dashed boxes in Figure 2). These differences 234 
were presented using Venn diagrams for each enzyme. The number of peptides with high 235 
peak intensity (threshold of 3 × 10
5
) was 238 and 236 for the WPH-P and WPH-PL samples, 236 
respectively. The Venn diagrams showed that most peptides with high intensity were 237 
common in hydrolysates generated at the three pH conditions (169 and 176 common peptides 238 
for WPH-P and WPH-PL samples, respectively, Figure 3). These peptides generally had the 239 
same intensity in the three WPH samples produced with the same enzyme. Sixty-nine 240 
peptides, ranging from 519.308 to 1315.228 m/z showed intensity differences between the 241 
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WPH-P samples. For example, the highest intensity peak (657.869 m/z and elution time of 242 
62.7 min) had intensities of 10.0 ± 0.5 × 10
6
, 5.2 ± 0.8 × 10
6
 and 2.0 ± 0.5 × 10
6
 for WPH-P-243 
no pH stat, WPH-P-pH 6.3 and WPH-P-pH 7, respectively. Therefore, this peptide was 244 
reported in the Venn diagram for the WPH-P-no pH stat sample (Figure 3A), among the 245 
twenty-one peptides that had their highest intensities for WPH-P-no pH stat. However, no 246 
clear pattern could be observed concerning the effect of each pH condition on the intensity of 247 
the peptides released. Similar deductions could be proposed for the WPH-PL samples, which 248 
had 60 peptides with different intensities ranging from 519.374 to 1451.066 m/z. 249 
 250 
3.4 Bioactive properties 251 
The DPP-IV IC50 values were significantly lower for all the WPH compared to 252 
unhydrolysed WP (P < 0.05, Table 1). All the WPH-P samples were of the same IC50 order 253 
(P > 0.05) with the lowest IC50 at 1.40 ± 0.12 mg mL
-1
 for WPH-P-pH 6.3. The IC50 of the 254 
pH stat samples, WPH-PL-pH 7 and WPH-PL-pH 6.1, were significantly lower than the 255 
value for their non pH stated equivalent (WPH-PL-no pH stat) (P < 0.05), with IC50 of 1.01 ± 256 
0.09 and 1.82 ± 0.26 mg mL
-1
 for WPH-PL-pH 6.1 and WPH-PL-no pH stat, respectively. 257 
The pH stated WPH-PL-pH 7 sample had the lowest IC50 values of all the WPH (IC50 of 0.72 258 
± 0.08 mg mL
-1
, P < 0.05). 259 
The ORAC values of all the WPH were significantly higher than that of unhydrolysed 260 
WP (P < 0.05, Table 1). There was no significant difference between the ORAC values of the 261 
WPH-PL samples (P > 0.05). The ORAC value of the WPH-P-no pH stat sample was 262 
significantly lower than that of WPH-P-pH 7 (P < 0.05), with values of 192.54 ± 42.61 and 263 
285.32 ± 36.71 µmol TE g
-1
 protein equivalent, respectively. 264 
 265 
4 Discussion 266 
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 267 
The use of pH regulation to generate protein hydrolysates is important in laboratory 268 
environments to control enzymatic hydrolysis reactions. However, in an industrial context, 269 
pH regulation during hydrolysis may need to be avoided in order to (i) minimise the inclusion 270 
of additives, (ii) avoid possible contaminations and (iii) simplify the hydrolysis protocols. A 271 
previous study reported a 22 % decrease in in vitro insulin secretion by pancreatic -cells 272 
following stimulation with a WPH generated without pH regulation as compared to a WPH 273 
generated with pH regulation (Nongonierma, Gaudel, et al., 2013). However, to our 274 
knowledge, the impact of WPH generation in pH controlled vs. non pH controlled conditions 275 
has not been systematically studied in the context of antioxidant and DPP-IV inhibitory 276 
bioactivities. Therefore, this study investigated the generation of WPH in different pH 277 
environments and analysed their impact on hydrolysates bioactivities and physicochemical 278 
properties. 279 
 280 
The ORAC values obtained were shown to be dependent on pH conditions used to 281 
generate the hydrolysates. The higher ORAC values were observed for hydrolysates 282 
generated at the constant optimal enzyme pH (i.e., pH 7.0) for papain and papain-like enzyme 283 
preparations. The hydrolysis generated under pH stat conditions also displayed more potent 284 
the DPP-IV inhibitory activities compared to non-pH stat hydrolysates. The bioactive 285 
differences between samples generated under different pH conditions may be due to pH-286 
dependant changes in enzymes conformation (Whitehurst, et al., 2002). Indeed, alteration of 287 
enzymatic activity under different pH conditions may have influenced the peptides released. 288 
Therefore, this study has highlighted the importance for considering the use or otherwise of 289 
pH controlled conditions depending on the applications of the hydrolysates, i.e., generation of 290 
the more potent bioactive hydrolysate or importance of reducing the additives incorporation. 291 
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Many studies have reported ORAC values and in vitro DPP-IV inhibitory activity for 292 
milk protein hydrolysates (Di Pierro, O’Keeffe, Poyarkov, Lomolino & FitzGerald, 2014; 293 
Lacroix & Li-Chan, 2014; Nongonierma & FitzGerald, 2013a). The ORAC values reported 294 
herein were of the same order as in previous studies. For instance, Power (2013) reported 295 
similar ORAC values for WPH hydrolysates. The DPP-IV IC50 obtained in this study were 296 
also of the same order as those in the literature. For example, IC50 of 1.43 ± 0.27 mg mL
-1
 297 
and 1.33 ± 0.17 mg mL
-1
 were previously reported for WPH generated with food-grade 298 
gastrointestinal enzyme preparations and Corolase PP, respectively (Nongonierma & 299 
FitzGerald, 2013a, 2013b) 300 
 301 
Most of peptides observed by LC-MS were common within all WPH samples 302 
hydrolysed with the same enzyme preparation. However, some peptides showed different 303 
peak intensity in MS depending of the pH conditions employed. These peptides, along with 304 
peptides poorly represented in MS may be responsible for both the DPP-IV inhibitory and the 305 
ORAC activity variations between samples. The identity of these peptides was not 306 
investigated herein, however they all had m/z values inferior to 1500 Da. Short milk-derived 307 
peptides (< 11 amino acids), containing one or more residues of histidine, proline, tyrosine 308 
and tryptophan, have already been reported as displaying antioxidative properties (Pihlanto, 309 
2006). Similarly, most DPP-IV inhibitory peptides reported in the literature to date appear to 310 
possess < 8 amino acid residues. In general peptides comprising a Trp at the N-terminus 311 
and/or a Pro at position 2 were generally potent DPP-IV inhibitors (Nongonierma & 312 
FitzGerald, 2014). 313 
 314 
The papain or microbially-derived papain-like enzyme preparations did not display 315 
similar WP hydrolysis in the conditions used herein. Indeed, the two preparations yielded 316 
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hydrolysates with significant differences such as their physicochemical properties. For 317 
example, a higher %DH and different peptide profiles were observed for the WPH-PL 318 
compared to the WPH-P samples. The DPP-IV inhibitory activities were also different; 319 
however the ORAC activities were of the same order for the samples produced with the 320 
papain or papain-like preparations for all pH conditions. Conversely, a previous study 321 
showed that these two enzyme preparations allowed the generations of quinoa hydrolysates 322 
with similar physicochemical and bioactive properties (Nongonierma, Le Maux, et al., 2015). 323 
Thus, the ability of the microbially-derived enzyme, used herein, to have the same properties 324 
as papain would seem to be substrate dependant. Indeed, these enzyme preparations were 325 
reported by the suppliers to contain several proteinases with broad specificities. Therefore, 326 
these enzymes may induce variable peptide cleavages on different protein substrates. 327 
 328 
5 Conclusions 329 
 330 
WPH generated with or without pH regulation showed similar physicochemical 331 
properties. However, some peptides exhibited different peak intensities in LC-MS, depending 332 
on the pH condition used during WPH generation. These differences in peptide composition 333 
may have contributed to the different bioactive properties of the samples. For example, WP 334 
hydrolysed with PL under pH regulation at 7.0 displayed more potent ORAC activity and 335 
DPP-IV inhibitory properties compared to the non pH controlled WPH. Consequently, the 336 
use of pH regulation vs. no pH regulation during enzymatic hydrolysis of WPs should be 337 
carefully considered as it was shown to affect peptide release and consequently the bioactive 338 
properties.  339 
Additionally, the difference between pH stat vs. non pH stat hydrolysis conditions 340 
should be established for different enzymes and different bioactivities. Further studies are 341 
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also required to elucidate the exact role of pH alteration on enzyme kinetics, potential effects 342 
on substrate conformation and hydrolysate specificity. Indeed, hydrolysis reaction are 343 
conventionally terminated on a time basis. However, as the objective of protein hydrolysis is 344 
to generate bioactive peptides, it would be interesting to use the hydrolysate bioactivity as the 345 
main parameter to stop the reaction. This could be achieved by having a better understanding 346 
of the kinetics of peptide release, which is dependant on conditions such as pH or temperature 347 
(Cheison, Leeb, et al., 2011). Finally, assessment of the peptides stability to gastrointestinal 348 
digestion is needed to verify that their bioactive properties can translate in vivo.  349 
 350 
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Table and Figure captions 
 
Table 1. Percentage of degree of hydrolysis (%DH), half maximum inhibitory concentration 
(IC50) for DPP-IV and ORAC of WP hydrolysed with papain (WPH-P) and the papain-like 
enzyme (WPH-PL) under different pH conditions (no pH stat, pH stat at 7, 6.3 or 6.1). The 
DPP-IV IC50 value of IPI, the positive control, was of 3.86 ± 0.50 µM. All values in the table 
are expressed in dry powder. Values represent the mean ± SD of three replicates (n = 3). For 
each assay, values with different superscript letters are significantly different (P < 0.05). TE: 
Trolox equivalent, NA: not applicable. 
 
Figure 1. Molecular mass distribution determined by GP-HPLC of WP hydrolysed with 
papain (WPH-P) and the papain-like enzyme (WPH-PL) under different pH conditions (no 
pH stat, pH stat at 7, 6.3 or 6.1). Bovine serum albumin, -lactoglobulin, -lactalbumin, 
aprotinin, bacitracin, Leu-trp-Met-Arg, Asp-Glu and tyrosine were used as standards. Values 
represent the mean ± SD of three replicates (n = 3). 
 
Figure 2. Representative RP-UPLC-MS base peak chromatograms (BPC) of WP hydrolysed 
with (A) papain (WPH-P) and (B) a papain-like enzyme (WPH-PL) under different pH 
conditions (no pH stat, black curve; pH stat at 7, dark grey curve; pH stat at 6.3 or 6.1 for 
WPH-P and WPH-PL respectively, light grey curve). Red dashed boxes indicate some peaks 
that presented different intensities for the different WPH samples. 
 
Figure 3. Venn diagram visualisation of peptide peaks common and specific to WP 
hydrolysed with (A) papain (WPH-P) and (B) a papain-like enzyme (WPH-PL) under 
different pH conditions (no pH stat, blue; pH stat at 7, yellow; pH stat at 6.3 or 6.1 for WPH-
 19 
 
P and WPH-PL respectively, magenta). Peptide peak intensity were assessed by RP-UPLC-
MS. Peptides with common intensity for several samples were represented at the intersection 
of these specific samples.  
 
Supplementary figure 1. Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
(SDS-PAGE) profiles of the whey protein (WP) hydrolysed with papain (WPH-P) and the 
papain-like enzyme (WPH-PL) in different pH conditions (no pH stat, pH stat at 7, 6.3 or 
6.1). Each hydrolysate was generated in triplicates. Samples were displayed as follow: (A) 
WP, WPH-P-no pH stat, WPH-P-pH 7; (B) WP, WPH-P-pH 6.3, WPH-PL-pH 6.1; (C) WP, 
WPH-PL-no pH stat WPH-PL-pH 7. Mw, molecular weight markers (6.5, 14.2, 20, 24, 29, 
36, 45, 55, 66, 97, 116, 200 kDa). 
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Table 1 
 
 
Sample DH (%) DPP-IV IC50 
(mg mL
-1
) 
ORAC values 
(µmol TE g
-1
) 
WP NA > 2.5 71.52 ± 19.29
 a
 
WPH-P-no pHstat 4.31 ± 0.38 
a
 1.54 ± 0.15
 c
 192.54 ± 42.61
 b
 
WPH-P-pH7 4.93 ± 0.06
 a
 1.48 ± 0.18
 c
 285.32 ± 36.71
 cd
 
WPH-P-pH6.3 5.36 ± 0.50
 a
 1.40 ± 0.12
 c
 231.90 ± 25.40
 bc
 
WPH-PL-no pHstat 9.41 ± 0.12
 b
 1.82 ± 0.26
 d
 258.02 ± 21.92
 cd
 
WPH-PL-pH7 10.80 ± 0.32
 b
 0.72 ± 0.08
 a
 308.24 ± 56.13
 d
 
WPH-PL-pH6.1 8.98 ± 1.49
 b
 1.01 ± 0.09
 b
 249.92 ± 26.41
 bd
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Figure 3 
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Supplementary figure 1 
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Mw       WPH-P-         WP         WPH-P-        WP   
Mw 
                 pH 7                         no pH stat 
Mw         WPH-PL-           WP         WPH-PL-           WP   
Mw 
                    pH 7                            no pH stat 
Mw       WPH-P-         WP       WPH-PL-       WP    
Mw 
               pH 6.3                       pH 6.1 
